The company's equity base has contracted to $13.3 million in 2026Q1 from $34.2 million in 2023Q4, reflecting a persistent erosion of shareholder value alongside an increasing reliance on debt.
| Total Current Assets | 47.17M | 61.55M | 58.12M | 93.79M | 98.77M | 115.33M | 65.01M | 88.45M | 114.47M | 37.01M | 22.92M |
| Cash & Short-Term Investments | 13.21M | 34.36M | 19.66M | 60.58M | 71.88M | 96.34M | 50.84M | 76.59M | 104.58M | 29.15M | 17.04M |
| Cash Only | 13.21M | 34.13M | 19.46M | 59.68M | 70.34M | 94.14M | 48.96M | 75.71M | 104.58M | 29.15M | 17.04M |
| Short-Term Investments | 0 | 225K | 206K | 905K | 1.54M | 2.2M | 1.89M | 880K | 0 | 0 | 0 |
| Accounts Receivable | 16.21M | 16.89M | 24.29M | 17.84M | 13.82M | 7.78M | 7.17M | 6.57M | 5.62M | 4.27M | 3.58M |
| Days Sales Outstanding | 47.5 | 41.34 | 118.36 | 91.26 | 77.36 | 51.34 | 53.11 | 38.27 | 38.87 | 38.52 | 38.14 |
| Inventory | 4.71M | 4.33M | 4.25M | 8.09M | 8.9M | 6.56M | 3.72M | 2.77M | 2.43M | 2.47M | 1.7M |
| Days Inventory Outstanding | 21.17 | 20.55 | 74.8 | 150.38 | 209.79 | 205.57 | 117.52 | 65.82 | 71.32 | 93.52 | 93.48 |
| Other Current Assets | 13.04M | 5.97M | 6.85M | 4.77M | 2.17M | 3.09M | 2.19M | 1.83M | 1.84M | 1.12M | 607K |
| Total Non-Current Assets | 78.27M | 80M | 82.78M | 22.04M | 18.11M | 25.89M | 13.64M | 11.72M | 2.55M | 1.93M | 1.88M |
| Property, Plant & Equipment | 26.94M | 28.03M | 33.34M | 4.78M | 5.32M | 5.1M | 4.15M | 4.9M | 1.38M | 1.36M | 1.63M |
| Fixed Asset Turnover | 5.32x | 5.32x | 2.25x | 14.92x | 12.26x | 10.84x | 11.87x | 12.78x | 38.30x | 29.75x | 21.02x |
| Goodwill | 23.62M | 23.62M | 18.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 17.79M | 18.15M | 19.61M | 0 | 0 | 0 | 0 | 0 | 1M | 400K | 0 |
| Long-Term Investments | 775K | 249K | 86K | 661K | 1.22M | 1.7M | 2.33M | 1.73M | 0 | 0 | 0 |
| Other Non-Current Assets | 9.81M | 9.95M | 11.12M | 16.59M | 11.57M | 19.09M | 7.17M | 5.08M | 171K | 174K | 250K |
| Total Assets | 125.44M | 141.55M | 140.9M | 115.83M | 116.88M | 141.22M | 78.66M | 100.17M | 117.02M | 38.94M | 24.8M |
| Asset Turnover | 1.11x | 1.05x | 0.53x | 0.62x | 0.56x | 0.39x | 0.63x | 0.63x | 0.45x | 1.04x | 1.38x |
| Asset Growth % | 124.15% | 0.46% | 21.65% | -0.9% | -17.23% | 79.54% | -21.47% | -14.4% | 200.53% | 57.02% | - |
| Total Current Liabilities | 28.29M | 30.52M | 31.27M | 19.81M | 33.2M | 15.7M | 13.68M | 27.69M | 13.56M | 11.99M | 13.34M |
| Accounts Payable | 11.43M | 10.74M | 11.08M | 4.75M | 2.43M | 4.3M | 3.75M | 4.63M | 3.76M | 2.51M | 1.48M |
| Days Payables Outstanding | 50.27 | 51.01 | 195.05 | 88.3 | 57.36 | 134.66 | 118.43 | 109.7 | 110.14 | 95.23 | 81.74 |
| Short-Term Debt | 5.42M | 5.56M | 0 | 0 | 13.13M | 0 | 0 | 11.25M | 0 | 0 | 4.49M |
| Deferred Revenue (Current) | 3.23M | 753K | 974K | 1.62M | 1.98M | 2.5M | 2.02M | 2.23M | 2.25M | 1.97M | 1.33M |
| Other Current Liabilities | 10.6M | 13.47M | 8.95M | 8M | 11.2M | 5.09M | 5.02M | 5.72M | 2.64M | 2.72M | 2.37M |
| Current Ratio | 1.67x | 2.02x | 1.86x | 4.73x | 2.98x | 7.34x | 4.75x | 3.19x | 8.44x | 3.09x | 1.72x |
| Quick Ratio | 1.50x | 1.87x | 1.72x | 4.33x | 2.71x | 6.93x | 4.48x | 3.09x | 8.26x | 2.88x | 1.59x |
| Cash Conversion Cycle | 18.4 | 10.88 | -1.89 | 153.34 | 229.8 | 122.25 | 52.2 | -5.61 | 0.04 | 36.81 | 49.88 |
| Total Non-Current Liabilities | 80.09M | 84.79M | 77.84M | 61.83M | 26.63M | 40.34M | 39.48M | 24.62M | 32.42M | 219.6M | 188.58M |
| Long-Term Debt | 18.67M | 65.81M | 55.15M | 59.28M | 22.83M | 35.34M | 34.62M | 19.9M | 30.39M | 29.56M | 15.65M |
| Capital Lease Obligations | 58.23M | 18.93M | 22.69M | 2.35M | 2.97M | 3.54M | 3.12M | 2.62M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -167K |
| Other Non-Current Liabilities | 61.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86K | 187.76M | 172.94M |
| Total Liabilities | 108.38M | 115.31M | 109.1M | 81.64M | 59.82M | 56.05M | 53.16M | 52.32M | 45.98M | 231.59M | 201.92M |
| Total Debt | 24.09M | 90.3M | 82.63M | 62.47M | 39.74M | 39.54M | 38.34M | 34.33M | 30.39M | 29.56M | 20.14M |
| Net Debt | 10.88M | 56.17M | 63.17M | 2.8M | -30.59M | -54.6M | -10.62M | -41.38M | -74.19M | 409K | 3.1M |
| Debt / Equity | 1.41x | 3.44x | 2.60x | 1.83x | 0.70x | 0.46x | 1.50x | 0.72x | 0.43x | - | - |
| Debt / EBITDA | -0.90x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.40x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.43x | -3.74x | -5.00x | -4.57x | -9.34x | -8.45x | -5.93x | -7.67x | -5.53x | -4.72x | -5.12x |
| Total Equity | 17.06M | 26.24M | 31.8M | 34.19M | 57.06M | 85.17M | 25.49M | 47.85M | 71.04M | -192.65M | -177.12M |
| Equity Growth % | 222.49% | -17.48% | -6.99% | -40.08% | -33.01% | 234.11% | -46.73% | -32.64% | 136.88% | -8.77% | - |
| Book Value per Share | 0.25 | 0.40 | 1.00 | 1.19 | 2.12 | 3.34 | 1.35 | 2.60 | 7.94 | -17170.41 | -15786.45 |
| Total Shareholders' Equity | 13.27M | 22.38M | 27.71M | 34.19M | 57.06M | 85.17M | 25.49M | 47.85M | 71.04M | -192.65M | -177.12M |
| Common Stock | 696K | 690K | 557K | 291K | 273K | 264K | 191K | 186K | 177K | 2K | 2K |
| Retained Earnings | -469.58M | -458.79M | -419.79M | -376.08M | -345.89M | -308.73M | -277.54M | -250.09M | -221.04M | -196.95M | -180.89M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.23M | 3.71M |
| Minority Interest | 3.79M | 3.86M | 4.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and solvency pressure
According to quarterly balance sheet data, Neuronetics' equity base has contracted significantly from $34.2 million in 2023Q4 to $13.3 million in 2026Q1, reflecting a persistent erosion of shareholder value driven by ongoing operational losses and an increasing reliance on debt to fund the business.
The consistent decline in equity, coupled with a widening accumulated deficit, suggests that the company's current business model is failing to generate the internal capital necessary for self-sustainment. Investors should monitor whether this trajectory forces further dilutive equity raises or restrictive debt restructuring in the coming quarters.
As reported in financial filings, the company's debt-to-equity ratio has surged to 1.41 in 2026Q1 from 1.83 in 2023Q4, indicating that management is increasingly leveraging the balance sheet to offset operational cash burn while facing a shrinking equity cushion to absorb potential future losses.
The reliance on debt in a high-interest environment appears to be a necessity-driven strategy rather than a tactical capital allocation choice. This leverage profile limits financial flexibility and increases the risk of covenant breaches if the company fails to achieve its targeted revenue growth and margin expansion.
Based on the provided balance sheet, the emergence of $23.6 million in goodwill by 2026Q1, which was previously non-existent, suggests that recent inorganic growth strategies have introduced significant intangible risk that may require future impairment testing if the acquired assets fail to meet performance expectations.
The shift toward a more asset-heavy profile, characterized by rising goodwill and fixed assets, complicates the company's liquidity position. This transition warrants further investigation into the underlying quality of these assets and whether they provide the anticipated operational synergies to justify their carrying values.
Data from recent financial statements reveals that cash reserves have plummeted from $59.7 million in 2023Q4 to $13.2 million in 2026Q1, leaving the company with a precarious liquidity buffer that appears insufficient to support its current operating burn rate for an extended period.
The decline in the current ratio to 1.67 suggests that the company's ability to meet short-term obligations is tightening rapidly. Without a meaningful improvement in cash flow generation, the current liquidity position may necessitate external financing, which could further dilute existing shareholders or increase the interest burden.
Quick answers to the most common questions about buying STIM stock.
As of 2025, Neuronetics, Inc. (STIM) had total assets of $141.6M including $61.6M in current assets.
Neuronetics, Inc. (STIM) carries total debt of $90.3M, offset by $34.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Neuronetics, Inc. (STIM) has total shareholders' equity (book value) of $22.4M ($0.40 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Neuronetics, Inc. (STIM) reported a current ratio of 2.02x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.